Jon Serbousek

Orthofix Medical has named Jon Serbousek as president of its Global Spine business (effective 5 August 2019). Serbousek is also to succeeds Brad Mason, the company’s retiring president and Chief Executive Officer (CEO), to be effective 1 November 2019.

A seasoned executive with more than 30 years’ experience in the medical device and biotech industries, Serbousek served in several leadership positions at Biomet, including worldwide president of Biomet Biologics, worldwide group president of Orthopedics, and president of US Orthopedics. Prior to joining Biomet, he held various general management positions within Medtronic including worldwide division president, Spine, worldwide vice president and general manager of Biologics for their Spine and Biologics business.

Additionally, Serbousek spent 13 years with DePuy Orthopedics, a Johnson & Johnson company where he served in numerous roles of increasing responsibility, including the vice president of Marketing and Product Development and as vice president of Spinal Operations.

Brad Mason, Orthofix president and current CEO, says: “Jon’s expertise and proven track record are perfectly aligned with our business composition and make him an exceptional choice to lead the company as president and CEO. With the recent leadership change in our spine business, I am pleased that Jon has agreed to serve as the president of Global Spine on an interim basis. This will give him time to focus on our needs and opportunities in that business before he takes on the broader CEO role, which should help ensure a seamless leadership transition for the benefit of all Orthofix stakeholders.”